{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-08-13T12:23:42.139353+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-12T18:34:19+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "The 5 Most Interesting Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call - ca.finance.yahoo.com",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNNGNqYzVrVEdielZ0MXM5TVB3SWNrT1p5VDd6NVI5LUs0WXhsQlVJc2Q1R1NVTG5qenZRUHkza2gzVU9NeUVVaWlXQjRBQThqZ3FQV01nbE51OHdLRFR4bE1hZHY4VUpfUUlibkFSanY0bW0zdmZGcmREeE1KaGFGYkJKMTFXd1NqNUZzcjNR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNNGNqYzVrVEdielZ0MXM5TVB3SWNrT1p5VDd6NVI5LUs0WXhsQlVJc2Q1R1NVTG5qenZRUHkza2gzVU9NeUVVaWlXQjRBQThqZ3FQV01nbE51OHdLRFR4bE1hZHY4VUpfUUlibkFSanY0bW0zdmZGcmREeE1KaGFGYkJKMTFXd1NqNUZzcjNR?oc=5\" target=\"_blank\">The 5 Most Interesting Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">ca.finance.yahoo.com</font>",
      "published": "2025-08-13T04:01:00+00:00",
      "source": "ca.finance.yahoo.com"
    },
    {
      "title": "Stock Analysis | Vertex Pharmaceuticals Outlook - Technical Neutrality and Mixed Analyst Sentiment - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZUpOSWo2N3YybDQwcUp2UXpBb0dEWlFvT0g2bURsY3RvM1JOM0JfRGtOdGtrS2NiTU9EUndlQkwtZGxCLURCeUlkWnRMTDgxZEx4SWExSnhDR3NER2xpdjg0ZDdacUtld2FlRWpfekJwbFdUUkUzM01Cb3ptb3htdnRYSDdaeVNwR21CaThxcm0yWEFLR1ZxOHRxRG1HVi1oenZvNFVCQVlYcnFnXzViS0paTGkxNXgwUzRxMG1tNE82SFk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZUpOSWo2N3YybDQwcUp2UXpBb0dEWlFvT0g2bURsY3RvM1JOM0JfRGtOdGtrS2NiTU9EUndlQkwtZGxCLURCeUlkWnRMTDgxZEx4SWExSnhDR3NER2xpdjg0ZDdacUtld2FlRWpfekJwbFdUUkUzM01Cb3ptb3htdnRYSDdaeVNwR21CaThxcm0yWEFLR1ZxOHRxRG1HVi1oenZvNFVCQVlYcnFnXzViS0paTGkxNXgwUzRxMG1tNE82SFk?oc=5\" target=\"_blank\">Stock Analysis | Vertex Pharmaceuticals Outlook - Technical Neutrality and Mixed Analyst Sentiment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-13T03:24:12+00:00",
      "source": "AInvest"
    },
    {
      "title": "The 3 Things That Matter for Vertex Pharmaceuticals Now - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNWl9vejVmVmZ1bzVtRlBYYUI4X3lwTXhidXU4ZUExQWV0YXRtdXlsaFduSy1xb0dRc1otM0JUUjlTTmhmVERDWnBsVnhVVG53QnRzc3JmZGdQV0RnS1g0cS1lN3ZMRjFncFB1VGZ4bVpWMEw0d3B0bTNQeEVDMjFiVTFyMDY2Q3VDQ3JhVXI3N0FQTnFPLW4xag?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxNWl9vejVmVmZ1bzVtRlBYYUI4X3lwTXhidXU4ZUExQWV0YXRtdXlsaFduSy1xb0dRc1otM0JUUjlTTmhmVERDWnBsVnhVVG53QnRzc3JmZGdQV0RnS1g0cS1lN3ZMRjFncFB1VGZ4bVpWMEw0d3B0bTNQeEVDMjFiVTFyMDY2Q3VDQ3JhVXI3N0FQTnFPLW4xag?oc=5\" target=\"_blank\">The 3 Things That Matter for Vertex Pharmaceuticals Now</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-07-28T07:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Daiwa Securities Adjusts Price Target on Vertex Pharmaceuticals to $430 From $530, Maintains Buy Rating - MarketScreener",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPX2Z0RmpEOG5MckxZYzlGR2tyZ0hGWVptT3J1cjZpX1h0bHZVSHpOS3p5ZXVGNGZ2YWh5ZUVQUU5RNlJwN2k5cFUxbFZIV2Z6NWZCeHpPczBLdi1rQ2dPUmNZWnM0dXNfTGdJdHVGR1NLcXZIRHlJMWxTQ0xRenlLMGw1X0JWVWRUN1JnaDNQODlpcXBDVEpDNTA3ZXNCY2NFRkRlWGl4V29Yc3hhTUVNd29UbjB5WHN3azV0SXFWd2hZb0lEZkl4VHFHY3JwMW5XYk1BaWlienVhZThwVWNXd0U5Slo?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPX2Z0RmpEOG5MckxZYzlGR2tyZ0hGWVptT3J1cjZpX1h0bHZVSHpOS3p5ZXVGNGZ2YWh5ZUVQUU5RNlJwN2k5cFUxbFZIV2Z6NWZCeHpPczBLdi1rQ2dPUmNZWnM0dXNfTGdJdHVGR1NLcXZIRHlJMWxTQ0xRenlLMGw1X0JWVWRUN1JnaDNQODlpcXBDVEpDNTA3ZXNCY2NFRkRlWGl4V29Yc3hhTUVNd29UbjB5WHN3azV0SXFWd2hZb0lEZkl4VHFHY3JwMW5XYk1BaWlienVhZThwVWNXd0U5Slo?oc=5\" target=\"_blank\">Daiwa Securities Adjusts Price Target on Vertex Pharmaceuticals to $430 From $530, Maintains Buy Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>",
      "published": "2025-08-13T10:25:30+00:00",
      "source": "MarketScreener"
    },
    {
      "title": "Advocates urge South Africa to reopen antitrust probe into Vertex Pharmaceuticals - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNa29lMEJqdk1mYm4ycTltcXBaTUprcW5vTFJNRjZzN092anY2Z3AteTVsbTh6MTM1Q3dTT2R6NEd3elVJRnRMZFYyZlNFdGpxeHZwdUxUNTZveWtlS2RVUXIyZDJkZ2p4ZjB4eTFUZ01qMTBuT1dDVHBMVXZQRnRldWdmTFVvYVFqLWNkclU3SzAyYW5JMkZOQXNOcnN1LU9VUTBLNHkxZFkyMXB4TEEzQnM4c0tuanJqMjFPeGRRSXE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNa29lMEJqdk1mYm4ycTltcXBaTUprcW5vTFJNRjZzN092anY2Z3AteTVsbTh6MTM1Q3dTT2R6NEd3elVJRnRMZFYyZlNFdGpxeHZwdUxUNTZveWtlS2RVUXIyZDJkZ2p4ZjB4eTFUZ01qMTBuT1dDVHBMVXZQRnRldWdmTFVvYVFqLWNkclU3SzAyYW5JMkZOQXNOcnN1LU9VUTBLNHkxZFkyMXB4TEEzQnM4c0tuanJqMjFPeGRRSXE?oc=5\" target=\"_blank\">Advocates urge South Africa to reopen antitrust probe into Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-08-08T16:13:27+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5\" target=\"_blank\">Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-08-05T20:20:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Vertex's trial failure, scrapped study cloud pain drug push; shares slump - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQOEk3LXI4VjBsT0J1aDNCc3BvU3ZZYTgzRlBGOEFuejM3QzFST3lZT3hMUGtNVFFDazVoblY1bUM3bHo2Q1BpOXdCMGx2b0ZvS19qNFl1M3AzUG9zQ1haaWU2Wnk4Y1ZzaEVRRC14RExYMWh3MGM2OWRFekF6NW1yNjhzeXNySFVqc1hhdEdlMjI3ZG4tcnVIdWNGeVI3eU9PSzA5eVdvQVBRNVJETFI5SGtRZDhPWkhxVFllcmp3U3NsZVRfRDRxdGNLbExUS29JcDhkMlV0YTBSQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQOEk3LXI4VjBsT0J1aDNCc3BvU3ZZYTgzRlBGOEFuejM3QzFST3lZT3hMUGtNVFFDazVoblY1bUM3bHo2Q1BpOXdCMGx2b0ZvS19qNFl1M3AzUG9zQ1haaWU2Wnk4Y1ZzaEVRRC14RExYMWh3MGM2OWRFekF6NW1yNjhzeXNySFVqc1hhdEdlMjI3ZG4tcnVIdWNGeVI3eU9PSzA5eVdvQVBRNVJETFI5SGtRZDhPWkhxVFllcmp3U3NsZVRfRDRxdGNLbExUS29JcDhkMlV0YTBSQQ?oc=5\" target=\"_blank\">Vertex's trial failure, scrapped study cloud pain drug push; shares slump</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex Reports Second Quarter 2025 Financial Results - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOOExBZmhVaExxYmNrR3k1S1Rlc2MyYkFlQ09oS05WNUtJalFvMmV2Y0hFN294alU0UzF3bGMtOFU1VDZIVUd3aWljbmc5dGN3YWllbndqUDhnQ1l2RWFzSlFVZXlTd2o1TmVhZmtIVFNGb1R0QzNGV2dVZU4xOTVtUXZvaHUyMGs?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxOOExBZmhVaExxYmNrR3k1S1Rlc2MyYkFlQ09oS05WNUtJalFvMmV2Y0hFN294alU0UzF3bGMtOFU1VDZIVUd3aWljbmc5dGN3YWllbndqUDhnQ1l2RWFzSlFVZXlTd2o1TmVhZmtIVFNGb1R0QzNGV2dVZU4xOTVtUXZvaHUyMGs?oc=5\" target=\"_blank\">Vertex Reports Second Quarter 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex Pharmaceuticals: A Masterclass in Diversified Innovation and Financial Discipline - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHpaSFhxbWZ5TkFaSlY2eDUwTW9fd2QwelRqS2tYQy1kclVuVmpjNHp2MmZCOGJ6UkZ2OVFicXlYcEhDSU9RZm9GWGJYWC0tTlFsc3NBdjFvaVA0V1lTX3h5Y29McmpaUGY1bDJma004M3FBTGc5OXh4b1p5MGNHWEhlUU1nNWI4ei1HTjBsRjBVbnJsZGtXdU5fNlpJS0QzaHc5VFZOSzZsbTF6SWxxRGZkaw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiswFBVV95cUxOZHpaSFhxbWZ5TkFaSlY2eDUwTW9fd2QwelRqS2tYQy1kclVuVmpjNHp2MmZCOGJ6UkZ2OVFicXlYcEhDSU9RZm9GWGJYWC0tTlFsc3NBdjFvaVA0V1lTX3h5Y29McmpaUGY1bDJma004M3FBTGc5OXh4b1p5MGNHWEhlUU1nNWI4ei1HTjBsRjBVbnJsZGtXdU5fNlpJS0QzaHc5VFZOSzZsbTF6SWxxRGZkaw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: A Masterclass in Diversified Innovation and Financial Discipline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "AInvest"
    },
    {
      "title": "Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5\" target=\"_blank\">Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-05-06T07:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-08-12",
      "close": 387.7699890136719
    },
    "history": [
      {
        "date": "2025-08-04",
        "close": 472.2699890136719
      },
      {
        "date": "2025-08-05",
        "close": 374.9800109863281
      },
      {
        "date": "2025-08-06",
        "close": 385.6499938964844
      },
      {
        "date": "2025-08-07",
        "close": 375.6300048828125
      },
      {
        "date": "2025-08-08",
        "close": 366.5400085449219
      },
      {
        "date": "2025-08-11",
        "close": 374.4599914550781
      },
      {
        "date": "2025-08-12",
        "close": 387.7699890136719
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}